- Presentations
- 2
- Markets
- 1
Ilumya is a brand of Tildrakizumab marketed by Sun Pharmaceutical Industries, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tildrakizumab
- Brand owner
- Sun Pharmaceutical Industries
- Registered in
- United States
- Strengths and forms
- 100 mg/1 mL injection, 100 mg/mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ilumya 100 mg/1 mL injectionSubcutaneous Cold chain | Sun Pharmaceutical IndustriesIndia | US FDA | Available on request |
| Ilumya 100 mg/mL injectionSubcutaneous Cold chain | Sun Pharmaceutical IndustriesIndia | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ilumya
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.